{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"columns":[{"gene":"","key":"MONDO:0032766/OMIM:618463","label":"Hypoalphalipoproteinemia, primary, 2","mondoId":"MONDO:0032766","onsetQualifier":null,"recordKeys":["11d910f9094ff703f40c10df5d9645579c89f22c5c64b0302acbb391896ecad5","23bd9a29344df709ca7883370d3b27e6e73d1e8f531d9a3f499a59062abd2f75","4a88c7a54fc830c89dd82e1d3899a42d4b099c73c3325467a4198082322f7dbd","524e033da010ec73e51e44531e78fc6686f7ad195c8dcce8955d09effee9fcd6","9f341841b50339942c2764be6a6d204730efcf8c688a8f027ebb7478d780a3c4"],"recordQualifiers":{},"scopeLabel":"OMIM:618463","sourceIds":["OMIM:618463"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0859238/OMIM:619836","label":"Hypoalphalipoproteinemia, primary, 2, intermediate","mondoId":"MONDO:0859238","onsetQualifier":null,"recordKeys":["404f6a3df520f30f0b9cdb1c180e540281f90d4de5677951af05233bf1b3469b","57d2e2948922a76855657cd343f896d9a2c2806a6b6ac7dde8850e25abf22aa9"],"recordQualifiers":{},"scopeLabel":"OMIM:619836","sourceIds":["OMIM:619836"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0032766/OMIM:618463","MONDO:0859238/OMIM:619836"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":5,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":7,"sourceGroups":{"omim":0,"orphanet":0,"published":7}},"features":[{"hpoId":"HP:0000518","label":"Cataract","primary":false},{"hpoId":"HP:0001084","label":"Corneal arcus","primary":false},{"hpoId":"HP:0031799","label":"Decreased circulating apolipoprotein A-I concentration","primary":false},{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":false},{"hpoId":"HP:0005181","label":"Premature coronary artery atherosclerosis","primary":false},{"hpoId":"HP:0010874","label":"Tendon xanthomatosis","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0032766","records":[{"frequencyKind":"count","key":"11d910f9094ff703f40c10df5d9645579c89f22c5c64b0302acbb391896ecad5","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:618463","disease_name":"Hypoalphalipoproteinemia, primary, 2","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0000518","is_excluded":false,"label":"Cataract","onset_id":null,"reference":"PMID:8282791","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"23bd9a29344df709ca7883370d3b27e6e73d1e8f531d9a3f499a59062abd2f75","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:618463","disease_name":"Hypoalphalipoproteinemia, primary, 2","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0010874","is_excluded":false,"label":"Tendon xanthomatosis","onset_id":null,"reference":"PMID:8282791","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"404f6a3df520f30f0b9cdb1c180e540281f90d4de5677951af05233bf1b3469b","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:619836","disease_name":"Hypoalphalipoproteinemia, primary, 2, intermediate","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"PMID:2512329","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"4a88c7a54fc830c89dd82e1d3899a42d4b099c73c3325467a4198082322f7dbd","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:618463","disease_name":"Hypoalphalipoproteinemia, primary, 2","evidence":"PCS","frequency_raw":"1/5","hpo_id":"HP:0001084","is_excluded":false,"label":"Corneal arcus","onset_id":null,"reference":"PMID:8282791","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"524e033da010ec73e51e44531e78fc6686f7ad195c8dcce8955d09effee9fcd6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:618463","disease_name":"Hypoalphalipoproteinemia, primary, 2","evidence":"PCS","frequency_raw":"2/5","hpo_id":"HP:0005181","is_excluded":false,"label":"Premature coronary artery atherosclerosis","onset_id":null,"reference":"PMID:8282791","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"57d2e2948922a76855657cd343f896d9a2c2806a6b6ac7dde8850e25abf22aa9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:619836","disease_name":"Hypoalphalipoproteinemia, primary, 2, intermediate","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0031799","is_excluded":false,"label":"Decreased circulating apolipoprotein A-I concentration","onset_id":null,"reference":"PMID:2512329","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9f341841b50339942c2764be6a6d204730efcf8c688a8f027ebb7478d780a3c4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:618463","disease_name":"Hypoalphalipoproteinemia, primary, 2","evidence":"PCS","frequency_raw":"5/5","hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"PMID:8282791","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"hypoalphalipoproteinemia-primary-2","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"hypoalphalipoproteinemia, primary, 2"},"schemaVersion":1}